If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

New epinephrine nasal spray dosage approved for pediatrics; FDA agree to review semaglutide for weight management; wearable defibrillator cleared to ...

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...

Outsourcing facilities can continue to compound semaglutide injectable drugs until May 22, after which date the FDA may take action against them. Recently, a separate federal court ruled in favor of ...

Mochi Health, which also develops a compounded version of Novo Nordisk’s GLP-1RA semaglutide ... wellness centres, and compounding pharmacies have been the target of lawsuits by the US drugmaker.

Empower describes itself as the nation’s largest compounding pharmacy — a type ... There have been reports of dosing errors associated with compounded semaglutide products, and some medical ...

While there is not currently a shortage of Ozempic, previous difficulties in supplying this medication have led to some pharmacies offering compounded semaglutide. The Food and Drug Administration ...

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide ... ensuring proper dosing and pharmaceutical-grade quality.

A standard dose of semaglutide is 2.4mg, but we start patients on much lower doses (0.25mg) and gradually build up to this by increasing the dose each month. This is because starting at the full ...